(Q35097361)

6 August 2017

1 reference

title

The case for early detection (English)

1 reference

6 August 2017

Garnet Anderson

8

0 references

author name string

Ruth Etzioni

1

1 reference

6 August 2017

Nicole Urban

2

1 reference

6 August 2017

Scott Ramsey

3

1 reference

6 August 2017

Martin McIntosh

4

1 reference

6 August 2017

Stephen Schwartz

5

1 reference

6 August 2017

Brian Reid

6

1 reference

6 August 2017

Jerald Radich

7

1 reference

6 August 2017

Leland Hartwell

9

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

6 August 2017

Nature Reviews Cancer

1 reference

6 August 2017

3

1 reference

6 August 2017

243-252

1 reference

6 August 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1038/nrc1041

6 August 2017

0 references

cites work

The performance of screening tests for ovarian cancer: results of a systematic review

1 reference

Early lung cancer action project: initial findings on repeat screenings.

31 March 2020

1 reference

Lung cancer screening with helical computed tomography in older adult smokers: a decision and cost-effectiveness analysis.

31 March 2020

1 reference

Lung cancer screening at any price?

31 March 2020

1 reference

Overdiagnosis Due to Prostate-Specific Antigen Screening: Lessons From U.S. Prostate Cancer Incidence Trends

31 March 2020

1 reference

Use of proteomic patterns in serum to identify ovarian cancer

31 March 2020

1 reference

Delineation of prognostic biomarkers in prostate cancer

31 March 2020

1 reference

Phases of biomarker development for early detection of cancer

31 March 2020

1 reference

Significance analysis of microarrays applied to the ionizing radiation response

31 March 2020

1 reference

Validating clustering for gene expression data.

31 March 2020

1 reference

Model-based clustering and data transformations for gene expression data

31 March 2020

1 reference

Prostate-specific antigen velocity and repeated measures of prostate-specific antigen

31 March 2020

1 reference

Screening of infants and mortality due to neuroblastoma

31 March 2020

1 reference

Determinants of survival following the diagnosis of esophageal adenocarcinoma (United States).

31 March 2020

1 reference

Secular trends in the epidemiology and outcome of Barrett's oesophagus in Olmsted County, Minnesota

31 March 2020

1 reference

Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia

31 March 2020

1 reference

Variable pathologic interpretation of columnar lined esophagus by general pathologists in community practice

31 March 2020

1 reference

Final results from 10 year cohort of patients undergoing surveillance for Barrett's oesophagus: observational study

31 March 2020

1 reference

The case-control design and the assessment of the efficacy of cancer screening.

31 March 2020

1 reference

Case-control studies of cancer screening: theory and practice

31 March 2020

1 reference

Case-control studies of the efficacy of screening for cancer: can we earn them some respect

31 March 2020

1 reference

Cancer surveillance series: interpreting trends in prostate cancer--part III: Quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality

31 March 2020

1 reference

Modeling the impact of the decline in distant stage disease on prostate carcinoma mortality rates.

31 March 2020

1 reference

The promise and peril of surrogate end points in cancer research

31 March 2020

1 reference

IV international conference on prevention and early detection of lung cancer, Reykjavik, Iceland, August 9-12, 2001.

31 March 2020

1 reference

Case-control evaluation of breast cancer screening efficacy

31 March 2020

1 reference

Breast self-examination in relation to the occurrence of advanced breast cancer

31 March 2020

1 reference

The Benefits and Risks of Mammographic Screening for Breast Cancer

31 March 2020

1 reference

A case-control study of the efficacy of a non-randomized breast cancer screening program in Florence (Italy)

31 March 2020

1 reference

A Case–Control Study of Screening Sigmoidoscopy and Mortality from Colorectal Cancer

31 March 2020

1 reference

The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status

31 March 2020

1 reference

Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria

31 March 2020

1 reference

Natural experiment examining impact of aggressive screening and treatment on prostate cancer mortality in two fixed cohorts from Seattle area and Connecticut

31 March 2020

1 reference

International trends in prostate-cancer mortality in the "PSA ERA".

31 March 2020

1 reference

Screening for prostate cancer: an update of the evidence for the U.S. Preventive Services Task Force

31 March 2020

1 reference

Cost-effectiveness of breast cancer screening: preliminary results of a systematic review of the literature

31 March 2020

1 reference

Screening mammography beginning at age 40 years: a reappraisal of cost-effectiveness

31 March 2020

1 reference

Cost-effectiveness of extending screening mammography guidelines to include women 40 to 49 years of age.

31 March 2020

1 reference

Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force

31 March 2020

1 reference

The cost-effectiveness of breast cancer screening.

31 March 2020

1 reference

Serial prostate specific antigen screening for prostate cancer: a computer model evaluates competing strategies

31 March 2020

1 reference

Comparative efficiency of prostate-specific antigen screening strategies for prostate cancer detection.

31 March 2020

1 reference

The value of a Pap smear program and suggestions for its implementation

31 March 2020

1 reference

Cervix cancer death rates and mass cytologic screening

31 March 2020

1 reference

Estimates of the worldwide incidence of eighteen major cancers in 1985.

31 March 2020

1 reference

Time to consider HPV testing in cervical screening

31 March 2020

1 reference

HPV for cervical cancer screening: is the era of the molecular pap smear upon us?

31 March 2020

1 reference

Human papillomavirus testing in primary cervical screening.

31 March 2020

1 reference

Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral

31 March 2020

1 reference

Combinations of multiple serum markers are superior to individual assays for discriminating malignant from benign pelvic masses

31 March 2020

1 reference

Elevation of multiple serum markers in patients with stage I ovarian cancer.

31 March 2020

1 reference

Clinical value of CYFRA 21.1, carcinoembryonic antigen, neurone-specific enolase, tissue polypeptide specific antigen and tissue polypeptide antigen in the diagnosis of lung cancer

31 March 2020

1 reference

Percent free prostate-specific antigen: the next frontier in prostate-specific antigen testing.

31 March 2020

1 reference

Prostate-specific antigen: current status

31 March 2020

1 reference

Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial

31 March 2020

1 reference

Strategies combining total and percent free prostate specific antigen for detecting prostate cancer: a prospective evaluation

31 March 2020

1 reference

Combination of multiple serum markers using an artificial neural network to improve specificity in discriminating malignant from benign pelvic masses.

31 March 2020

1 reference

Combining several screening tests: optimality of the risk score.

31 March 2020

1 reference

Identifying combinations of cancer markers for further study as triggers of early intervention

31 March 2020

1 reference

Development of a decision-making tool to predict risk of prostate cancer: the Cancer of the Prostate Risk Index (CAPRI) test.

31 March 2020

1 reference

Screening for ovarian cancer. We now need a definitive randomised trial

31 March 2020

1 reference

Re: Prostate cancer incidence and mortality in the United States and the United Kingdom

31 March 2020

1 reference

Prostate cancer: different incidence but not mortality trends within two areas of Tuscany, Italy

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRC1041

1 reference

release_2xzbhhis5vbmvcqdl6txeh7o6y

6 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2xzbhhis5vbmvcqdl6txeh7o6y

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference